Therapeutic potential of EGFR-related protein, a universal EGFR family antagonist (Q36429446)

14 August 2017

1 reference

title

Therapeutic potential of EGFR-related protein, a universal EGFR family antagonist (English)

1 reference

14 August 2017

Adhip P N Majumdar

1

1 reference

PubMed ID

16555995

14 August 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

14 August 2017

1 reference

14 August 2017

1

1 reference

14 August 2017

2

1 reference

14 August 2017

235-245

1 reference

14 August 2017

Cancer statistics, 1997.

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

21 January 2018

Protein-tyrosine kinases

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

Growth factor receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

Tyrosine-phosphorylated proteins: mediators of signal transduction from the tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

Autocrine growth factors and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

Regulation of prostatic growth and function by peptide growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

EGF receptor in neoplasia and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

Role of an anti-epidermal growth factor receptor in treating cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

Disulfide bond structure of human epidermal growth factor receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

The single transmembrane domains of ErbB receptors self-associate in cell membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

Cell signaling by receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

The ErbB signaling network: receptor heterodimerization in development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

The type I growth factor receptors in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

Untangling the ErbB signalling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

Amplification and expression of the c-erb B-2/neu proto-oncogene in human bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

Epidermal growth factor receptor: a promising target in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

Potential benefits of the irreversible pan-erbB inhibitor, CI-1033, in the treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

A truncated, secreted form of the epidermal growth factor receptor is encoded by an alternatively spliced transcript in normal rat tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

A 1.8 kb alternative transcript from the human epidermal growth factor receptor gene encodes a truncated form of the receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

Expression of a truncated EGF receptor is associated with inhibition of pancreatic cancer cell growth and enhanced sensitivity to cisplatinum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

Anti-oncogenic activity of signalling-defective epidermal growth factor receptor mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

Epidermal growth factor receptor-related protein: a potential therapeutic agent for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

Expression of EGF-receptor related protein (ERRP) decreases in gastric mucosa during aging and carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

Expression of epidermal growth factor-receptor related protein (ERRP) in human colorectal carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

Reduced expression of epidermal growth factor receptor-related protein in hepatocellular carcinoma: implications for cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

Reduced expression of epidermal growth factor receptor related protein in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

Epidermal growth factor receptor: association of extracellular domain negatively regulates intracellular kinase activation in the absence of ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.235

21 January 2018

Identifiers

DOI

10.1517/14796694.1.2.235

1 reference

14 August 2017

1 reference

PubMed ID

16555995